Ali Dibadj Chief Executive Officer Roger Thompson Chief Financial Officer Q2 2025 RESULTS Key metrics – Q2 2025 vs Q1 2025 | | Q2 2025 | Q1 2025 | | --- | --- | --- | | Investment outperformance3 3-/5-/10-year | 76/67/72% | 77/65/73% | | Total AUM1 | $457.3bn | $373.2bn | | Net flows2 | $46.7bn | $2.0bn | | U.S. GAAP diluted EPS | $0.95 | $0.77 | | Adjusted diluted EPS4 | $0.90 | $0.79 | | Dividend per share | $0.40 | $0.40 | Q2 2025 RESULTS Thursday, July 31, 2025 1 AUM and net flows include assets for whi ...

Core Insights - Merit Medical reported revenue of $382.46 million for the quarter ended June 2025, reflecting a 13.2% increase year-over-year, with EPS at $1.01 compared to $0.92 in the previous year [1] - The reported revenue met the Zacks Consensus Estimate, while the EPS exceeded the consensus estimate by 17.44% [1] Financial Performance Metrics - U.S. sales reached $227.08 million, surpassing the estimated $220.3 million, marking a 16.7% increase from the same quarter last year [4] - International sales amounted to $155.38 million, exceeding the estimated $151.04 million, representing an 8.4% year-over-year growth [4] - Revenue from Cardiovascular-Peripheral Intervention was $142.85 million, slightly below the estimated $144.62 million, with a year-over-year increase of 2.6% [4] - Cardiovascular-Cardiac Intervention revenue was $115.25 million, exceeding the estimated $104.93 million, showing a significant 22.8% increase year-over-year [4] - Endoscopy revenue reached $18.44 million, slightly below the estimated $18.66 million, but reflecting an impressive 81% increase from the previous year [4] - Cardiovascular-OEM revenue was $52.29 million, close to the estimated $52.65 million, with an 18.1% year-over-year increase [4] - Total Cardiovascular revenue was $364.03 million, surpassing the estimated $353.56 million, indicating an 11.1% increase year-over-year [4] - Revenue from Cardiovascular-Custom Procedural Solutions was $53.63 million, exceeding the estimated $51.05 million, with a year-over-year growth of 6.4% [4] Stock Performance - Merit Medical's shares have declined by 11.8% over the past month, contrasting with a 3.4% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Financial Performance - The company's revenues for Q2 2025 were $91.5 million, a 19.6% increase from $76.5 million in Q2 2024, and for the first six months of 2025, revenues were $182.8 million, up 23.3% from $148.2 million in the same period of 2024 [1][2] - Gross profit for Q2 2025 was $41.9 million, reflecting a 20.3% increase from $34.8 million in Q2 2024, and for the first six months of 2025, gross profit was $88.0 million, a 34.5% increase from $65.4 million in the same period of 2024 [2] - Net income for Q2 2025 was $30.8 million ($1.07 per diluted share), an 18.3% increase from $26.1 million ($0.91 per diluted share) in Q2 2024, and for the first six months of 2025, net income was $64.9 million ($2.26 per diluted share), a 33.9% increase from $48.5 million ($1.69 per diluted share) in the same period of 2024 [5] Expenses - Selling, general and administrative (SG&A) expenses were $6.2 million in Q2 2025, a 26.8% increase from $4.9 million in Q2 2024, and for the first six months of 2025, SG&A expenses were $12.5 million, up 28.0% from $9.7 million in the same period of 2024 [3] - Other income for Q2 2025 was $3.1 million, compared to $2.8 million in Q2 2024, and for the first six months of 2025, it was $6.2 million, up from $5.3 million in the same period of 2024, primarily due to interest earned on higher cash balances [4] Dividend Announcement - The company declared a quarterly cash dividend of $0.06 per share, payable on September 12, 2025, to shareholders of record as of August 22, 2025 [7] Company Overview - United States Lime & Minerals, Inc. is a manufacturer of lime and limestone products, serving various industries including construction, environmental, industrial, metals, agriculture, and oil and gas services [8]

浙商证券(601878.SH)公告称，2025年上半年实现 营业收入65.12亿元，同比下降18.60%；实现归属于上 市公司股东的 净利润11.49亿元，同比增长46.54%。公司总 资产较上年末增长29.25%。 ...

Core Insights - Franklin Financial Services Corporation reported strong financial results for the second quarter and year-to-date 2025, with significant increases in net income and asset growth [1][5][12]. Financial Performance - **Net Income**: For Q2 2025, net income was $5.9 million ($1.32 per diluted share), a 94.8% increase from $3.0 million ($0.66 per diluted share) in Q2 2024 [5][11]. - **Year-to-Date Net Income**: For the first six months of 2025, net income reached $9.8 million ($2.20 per diluted share), up 53.7% from $6.4 million ($1.43 per diluted share) in the same period of 2024 [12]. - **Net Interest Income**: Q2 2025 net interest income was $17.2 million, a 21.3% increase from $14.2 million in Q2 2024 [5][11]. - **Noninterest Income**: Noninterest income for Q2 2025 totaled $5.1 million, up 17.3% from $4.4 million in Q2 2024 [5][11]. Balance Sheet Highlights - **Total Assets**: As of June 30, 2025, total assets were $2.287 billion, a 4.1% increase from $2.198 billion at year-end 2024 [3][5]. - **Total Deposits**: Total deposits increased to $1.893 billion, up 4.3% from $1.814 billion at year-end 2024 [5][11]. - **Net Loans**: Total net loans reached $1.500 billion, an increase of 8.7% from December 31, 2024 [5][11]. Wealth Management - **Wealth Management Fees**: Fees for wealth management services were $2.4 million in Q2 2025, a 7.9% increase from $2.2 million in Q2 2024 [5][11]. - **Assets Under Management**: As of June 30, 2025, assets under management were $1.4 billion [5]. Performance Metrics - **Return on Average Assets (ROA)**: ROA for Q2 2025 was 1.04%, compared to 0.59% in Q2 2024 [5][13]. - **Return on Average Equity (ROE)**: ROE for Q2 2025 was 15.64%, up from 9.12% in Q2 2024 [5][13]. - **Net Interest Margin (NIM)**: NIM for Q2 2025 was 3.21%, compared to 2.99% in Q2 2024 [5][13]. Shareholder Information - **Dividends**: The Board of Directors declared a regular quarterly cash dividend of $0.33 per share for Q3 2025, payable on August 27, 2025 [5][11]. - **Shareholders' Equity**: Shareholders' equity increased to $157.4 million as of June 30, 2025, from $144.8 million at year-end 2024 [5][11].

Core Insights - Stellantis N.V. has published preliminary and unaudited financial information for the first half of 2025, indicating a net loss of €2.3 billion and net revenues of €74.3 billion [3][4]. Financial Performance - Estimated net revenues for the first half of 2025 are €74.3 billion, with a net loss of €2.3 billion and adjusted operating income of €0.5 billion [3]. - Cash flows from operating activities are reported at (€2.3) billion, while industrial free cash flows stand at (€3.0) billion [3]. Shipment Volumes - Global consolidated shipments for Q2 2025 are estimated at 1.4 million units, reflecting a 6% decline year-over-year [5][6]. - North America experienced a significant decline in shipments, down 25% year-over-year, totaling approximately 322 thousand units [12]. - In Enlarged Europe, shipments decreased by 6% year-over-year, with a decline of approximately 50 thousand units [12]. - Other regions, including Middle East & Africa and South America, saw increases in shipments, with 30% and 20% growth year-over-year, respectively [12]. Factors Impacting Performance - The decline in shipments is attributed to North American tariff-related production pauses and adverse impacts from product transitions in Enlarged Europe [6][7]. - Approximately €3.3 billion of pre-tax net charges were incurred, primarily related to program cancellations and platform impairments [7]. - The early effects of US tariffs resulted in €0.3 billion of net tariffs incurred, affecting planned production [7]. Upcoming Events - Stellantis will release detailed financial results for the first half of 2025 on July 29, 2025, followed by a conference call hosted by CEO Antonio Filosa and CFO Doug Ostermann [4][9].

Financial Performance - Medium stopped losing $2.6 million monthly [1] Company Strategy - Medium's CEO explains what it took to stop losing money [1]

Core Insights - Velan Inc. reported a strong financial performance for the first quarter of fiscal 2026, with sales growth of 18.6% and improved gross profit margins [3][4][5] - The company achieved a net income of $17.8 million, a significant turnaround from a net loss of $2.2 million in the same period last year [17][5] - Velan's cash and cash equivalents reached $59.1 million, the highest level in five years, following the divestiture of asbestos-related liabilities and the sale of French assets [3][19] Financial Results - Sales from continuing operations totaled $72.2 million, an increase of $11.3 million compared to $60.9 million in the previous year [5][12] - Gross profit rose to $20.6 million, representing a gross margin of 28.6%, up from 27.6% the previous year [5][13] - The company incurred restructuring expenses of $5.4 million, which included transaction-related costs [15][5] Backlog and Bookings - The backlog as of May 31, 2025, was $286.1 million, reflecting a 4.1% increase from $274.9 million at the end of the previous quarter [9][10] - Bookings for the quarter amounted to $78.2 million, down from $83.0 million in the prior year, resulting in a book-to-bill ratio of 1.08 [10][9] Significant Transactions - Velan completed the sale of its French subsidiaries for a total consideration of $208.2 million, resulting in a gain of $95.8 million recorded in the first quarter [7][8] - The company also settled its asbestos-related litigation for $143.0 million, funded partly by the proceeds from the sale of the French assets [8][7] Dividend Policy - The Board of Directors approved a significant increase in the quarterly dividend payment from CA$0.03 to CA$0.10 per common share, reflecting confidence in future performance [21][22] Outlook - The company expects to deliver solid performance in fiscal 2026, with 84.4% of the backlog deliverable within the next 12 months [20][4]

Core Insights - Velan Inc. reported a strong financial performance for the first quarter of fiscal 2026, with significant sales growth and improved gross profit margins [3][4][5] Financial Performance - Sales from continuing operations reached $72.2 million, an increase of $11.3 million or 18.6% compared to $60.9 million in the same period last year [5][11] - Gross profit rose to $20.6 million, representing a gross margin of 28.6%, up from 27.6% in the previous year [5][12] - Net income from continuing operations was $17.8 million, or $0.83 per share, compared to a net loss of $2.2 million, or a loss of $0.10 per share, in the prior year [5][16] Cash Position and Dividends - The company ended the quarter with cash and cash equivalents of $59.1 million, the highest level in five years, following the divestiture of asbestos-related liabilities and the sale of French assets [3][4][18] - A significant increase in the quarterly dividend payment was approved, raising it from CA$0.03 to CA$0.10 per common share, reflecting confidence in future performance [20][21] Backlog and Bookings - The backlog stood at $286.1 million, up 4.1% from $274.9 million at the end of the previous quarter, with 84.4% expected to be delivered within the next 12 months [9][19] - Bookings for the quarter amounted to $78.2 million, down from $83.0 million in the previous year, resulting in a book-to-bill ratio of 1.08 [10][19] Significant Transactions - The company completed the sale of its French subsidiaries for a total consideration of $208.2 million, resulting in a gain of $95.8 million recorded in the first quarter [7][8] - Concurrently, Velan sold its exposure to asbestos-related litigation in the U.S. for $143.0 million [8]

Core Viewpoint - Oportun's Board of Directors strongly supports the reelection of CEO Raul Vazquez and nominee Carlos Minetti, urging stockholders to vote "FOR" them on the GREEN proxy card, emphasizing their qualifications and the importance of continuity in leadership [2][17]. Company Leadership - Raul Vazquez has a proven leadership record, having transformed Oportun from a struggling regional lender into a national, digitally-driven financial services company, significantly increasing its loan portfolio from $100 million in 2012 to approximately $3 billion today [9][11]. - Vazquez's prior experience includes senior leadership roles at Walmart, where he oversaw a division generating over $60 billion in revenue and led significant growth in Walmart's e-commerce strategy [6][5]. Strategic Growth and Performance - Under Vazquez's leadership, Oportun expanded from two states to 41 states and diversified its product offerings, including secured loans and savings products [9]. - The company has returned to growth in loan originations and improved credit metrics, with a focus on cost reduction and operational efficiency, positioning it for strong financial results in 2025 [11][10]. Recognition and Impact - Oportun has received national recognition for its innovation and impact, being named one of the World's Most Innovative Companies by Fast Company and included in TIME magazine's list of "50 Businesses Inventing the Future" [14]. - Vazquez has been acknowledged for his leadership, serving on the boards of major companies like Staples and Intuit, and has received accolades such as the EY Entrepreneur of The Year® award in 2018 [12][14]. Stockholder Engagement - The Board emphasizes the importance of stockholder support for Vazquez's reelection, arguing that replacing him with a less qualified candidate would jeopardize the company's progress and disrupt its momentum [13][15]. - Stockholders are encouraged to visit VoteForOportun.com for more information on the company's progress and to support the current leadership [16].